Skip to main content
OpenTrials

Clinical trial condition

Dyslipidemias

Explore clinical trials studying Dyslipidemias. Study availability and eligibility vary by location and protocol.

1,810 public trials 143 recruiting studies
Refine in advanced search Browse all conditions

Dyslipidemias trial results

Completed

Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events

NCT01968967

Conditions
Dyslipidemias, Hyperlipidemia, Hyperlipidemias, +3 more
Locations
  • Ernest L. Hendrix, MD, PC Athens, Alabama, United States
  • North Alabama Research Center, LLC Athens, Alabama, United States
  • The Kirklin Clinic Birmingham, Alabama, United States
  • Alabama Internal Medicine, P.C. Birmingham, Alabama, United States
View all 249 locations
View Trial Details
Completed

Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events

NCT02100514

Conditions
Dyslipidemias, Hyperlipidemia, Hyperlipidemias, +3 more
Locations
  • Advanced Cardiovascular, LLC Research Alexander City, Alabama, United States
  • Advanced Cardiovascular, LLC, Research Auburn, Alabama, United States
  • Clinical Research Advantage, Inc./Family Practice Specialists, Ltd. Phoenix, Arizona, United States
  • Clinical Research Advantage, Inc./Family Practice Specialists, LTD Phoenix, Arizona, United States
View all 223 locations
View Trial Details
Completed

Phase III Study To Evaluate Alirocumab in Patients With Hypercholesterolemia Not Treated With a Statin (ODYSSEY CHOICE II)

NCT02023879

Conditions
Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
Locations
  • Investigational Site Number 840703 Beverly Hills, California, United States
  • Investigational Site Number 840704 Atlantis, Florida, United States
  • Investigational Site Number 840708 Jacksonville, Florida, United States
  • Investigational Site Number 840701 Sarasota, Florida, United States
View all 43 locations
View Trial Details
Completed

Open Label Study of Long Term Safety Evaluation of Alirocumab

NCT01954394

Conditions
Dyslipidemias, Hypercholesterolemia, Hyperlipidemias, +3 more
Locations
  • Investigational Site Number 840321 Huntsville, Alabama, United States
  • Investigational Site Number 840341 Tempe, Arizona, United States
  • Investigational Site Number 840334 Bell Gardens, California, United States
  • Investigational Site Number 840319 Fountain Valley, California, United States
View all 177 locations
View Trial Details

Related conditions